Eloise Chapman Davis, MD
Gynecologic Oncology · New York, NYNPI 1689707606
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $638 of the $1,003 with a category attached, or 63.6%. Medical Device Business Services, Inc. accounts for 84.7% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $891, 9.3 times the $96 reported in 2019. That places this record below the midpoint for gynecologic oncology clinicians in NY, where the typical reported total is $904.
Across 10 payments — averaging $100.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$849
- AstraZeneca$96
- Genmab U.S., Inc.$42
- Coopersurgical, Inc.$16
Across 43 payments — averaging $4721.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$197K
- Tesaro, Inc.$6K
What the payments were for
- Travel & lodging$63864%
- Food & beverage$36536%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 7 | $849 |
| AstraZeneca | 1 | $96 |
| Genmab U.S., Inc. | 1 | $42 |
| Coopersurgical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Harmonic$699
How this compares
$1,003 in reported general payments places this provider in the 50th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in New York
- Bhavana PothuriNew York$366K
- Mario LeitaoNew York$116K
- Konstantin ZakashanskyNew York$93K
- Evelyn CantilloNew York$79K
- Farr NezhatNew York$41K
- Kristen ZeligsNew York$38K
- Nimesh NagarshethNew York$33K
- Jeff LinNew York$30K
- Valentin KolevNew York$23K
- Jason WrightNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.